Dr. Michael David Sgroi, MD

Dr. Sgroi practices at Santa Clara Valley Medical Center in San Jose, California, part of County of Santa Clara, CA.

Dr. Sgroi's NPI, 1770801318, was assigned on May 6, 2010. Dr. Sgroi graduated from College of Human Medicine - Grand Rapids in 2010. Dr. Sgroi holds California license A121008.

Dr. Sgroi's primary practice is Santa Clara Valley Medical Center, at 751 South Bascom Avenue, San Jose, CA 95128 in Santa Clara County. The practice phone is (408) 885-5000.

Dr. Sgroi's primary practice is Santa Clara Valley Medical Center in San Jose, California, part of County of Santa Clara, CA. Dr. Sgroi is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Sgroi to 2 more medical groups, 1 community health center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sgroi practices, 4 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Sgroi's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Sgroi is board certified in anatomic pathology by the American Board of Pathology. Dr. Sgroi is licensed in California.

CMS data shows 308 Medicare services from Dr. Sgroi across 8 procedure codes in 2024, for 234 Medicare patients. Medicare paid $25,437 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 234 Medicare patients who saw Dr. Sgroi in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 82% are also on Medicaid. Their average risk score is 4.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sgroi's median patient age at 70, with 39% women.

In 2024, Dr. Sgroi wrote 37 Medicare Part D claims for 17 patients. 70% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $94 in total drug cost. In 2022, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 61 out of 100 for Dr. Sgroi for performance year 2024, reported as part of a group. Dr. Sgroi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sgroi as offering telehealth. CMS counts 62 procedures of removal of tissue by Dr. Sgroi, more than 81% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Sgroi in 2025. Dr. Sgroi's most frequent co-authors are Venita Chandra, MD, Arash Fereydooni and Andrea Tess Fisher, MD.

CMS Open Payments shows 97 general payments to Dr. Sgroi from 14 drug and device companies from 2016 to 2025. Grants make up the largest share, 56% of the total. Medtronic Vascular, Inc. paid the most, $17,853.

Dr. Sgroi graduated from College of Human Medicine - Grand Rapids in 2010.

Dr. Sgroi is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.